Manuscript
Post-trial Monitoring of a Randomised Controlled Trial of Intensive Glycaemic Control in Type 2 Diabetes Extended from 10 to 24 years (UKPDS 91)
Amanda I. Adler et al.
Lancet 2024
Manuscript
Are the cardiovascular properties of GLP-1 receptor agonists differentially modulated by sulfonylureas? insights from post-hoc analysis of EXSCEL,
K.M. Gooding et al.
Diabetes Res Clin Pract. 2024;212:111685
Manuscript
Regional variation in cause of death in patients with type 2 diabetes: insights from EXSCEL: Cause of Death in Type 2 Diabetes
Vishal N Rao et al.
Am Heart J. 2024;271:123-135
Manuscript
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
Pedro Cardoso et al.
Diabetologia 2024;67:822-836
Manuscript
Comparison of Medical Resources and Costs among Patients with Coronary Heart Disease and Impaired Glucose Tolerance in the Acarbose Cardiovascular Evaluation (ACE) Trial
Frauke Becker et al.
Journal of Diabetes 2023;16:e13473
Manuscript
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease. An Individual Participant Meta-Analysis
Stephen P Juraschek et al.
JAMA 2023;330:1459-1471